KODIAK SCIENCES INC. Operating Lease Right-of-Use Assets
KODIAK SCIENCES INC. (KOD) had Operating Lease Right-of-Use Assets of $32.30 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-13
- 2026-06-30: Operating Lease, Right-of-Use Asset $32.30M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $34.38M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $36.61M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $38.58M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $32.30M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $34.38M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $36.61M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $38.58M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $40.53M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $42.47M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $46.51M 10-K · filed 2026-03-31 |
| 2024-09-30 | $48.56M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $50.58M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $52.56M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $54.54M 10-K · filed 2025-03-27 |
| 2023-09-30 | $56.48M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $57.25M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $59.15M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $59.37M 10-K · filed 2024-03-28 |
| 2022-09-30 | $61.12M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $63.08M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $64.91M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $66.74M 10-K · filed 2023-03-28 |
| 2021-09-30 | $68.45M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $70.28M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $72.05M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $73.67M 10-K · filed 2022-03-01 |
| 2020-09-30 | $75.54M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $1.59M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $1.69M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $1.79M 10-K · filed 2021-03-01 |
| 2019-09-30 | $1.89M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $1.98M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $2.07M 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |